Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas.
Malignant gliomas are highly infiltrative and invasive tumors, which precludes the few treatment options available. Therefore, there is an urgent need to elucidate the molecular mechanisms underlying gliomas aggressive phenotype and poor prognosis. The Raf Kinase Inhibitory protein (RKIP), besides r...
Guardado en:
Autores principales: | Olga Martinho, Sara Granja, Teresa Jaraquemada, Cláudia Caeiro, Vera Miranda-Gonçalves, Mrinalini Honavar, Paulo Costa, Margarida Damasceno, Marsha R Rosner, José M Lopes, Rui M Reis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8803d99e3c3848b6869eb5ce816134e8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Characterization of the Raf kinase inhibitory protein (RKIP) binding pocket: NMR-based screening identifies small-molecule ligands.
por: Anne N Shemon, et al.
Publicado: (2010) -
Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas
por: Liguo Ye, et al.
Publicado: (2021) -
The RhoA dependent anti-metastatic function of RKIP in breast cancer
por: Gardiyawasam Kalpana, et al.
Publicado: (2021) -
Downregulation of STOX1 is a novel prognostic biomarker for glioma patients
por: Jin Fei-qin, et al.
Publicado: (2021) -
Cytotoxicity induced by carbon nanotubes in experimental malignant glioma
por: Romano-Feinholz S, et al.
Publicado: (2017)